Cargando...
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and dexamethasone is an effective sequential regimen for systemic amyloidosis (AL), dexamethasone is often poorly tolerated in patients with cardiac invol...
Guardado en:
| Publicado en: | J Clin Med Res |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elmer Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554222/ https://ncbi.nlm.nih.gov/pubmed/26346623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2303e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|